C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/47 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2470067
The present invention relates to adenosine A3 receptor ligands of the general formula (I), whithin those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containings them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and (III) and to the preparation thereof.
L'invention concerne des ligands des récepteurs de l'adénosine A¿3? de formule développée (I), de préférence des antagonistes, ainsi que des sels, des solvates et des isomères de ceux-ci, et des compositions pharmaceutiques les contenant. Elle porte également sur l'utilisation des composés de formule générale développée (I), ainsi que des sels, des solvates et des isomères de ceux-ci, sur la préparation des composés de formule générale développée (I) et des sels, des solvates et des isomères de ceux-ci, et sur des nouveaux intermédiaires des formules développées (II) et (III) et leur préparation.
Aranyi Peter
Balazs Laszlo
Balogh Maria
Batori Sandor
Boer Kinga
Fetherstonhaugh & Co.
Sanofi-Aventis
Sanofi-Synthelabo
LandOfFree
Imidazoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1971508